BioNote, Inc. (KRX:377740)

BioNote Revenue

BioNote had revenue of 28.45B KRW in the quarter ending March 31, 2025, with 12.39% growth. This brings the company's revenue in the last twelve months to 105.92B, up 12.42% year-over-year. In the year 2024, BioNote had annual revenue of 102.78B with 14.10% growth.

• Revenue (ttm): 105.92B
• Revenue Growth: +12.42%
• P/S Ratio: 4.88
• Revenue / Employee: 355.43M
• Employees: 298
• Market Cap: 516.94B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	102.78B	12.70B	14.10%
Dec 31, 2023	90.08B	-389.58B	-81.22%
Dec 31, 2022	479.66B	-142.70B	-22.93%
Dec 31, 2021	622.36B	-9.15B	-1.45%
Dec 31, 2020	631.50B	591.46B	1,476.89%